These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7948145)

  • 1. Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: implications for hepatic gene therapy.
    Gupta S; Vemuru RP; Lee CD; Yerneni PR; Aragona E; Burk RD
    Hum Gene Ther; 1994 Aug; 5(8):959-67. PubMed ID: 7948145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel system for transplantation of isolated hepatocytes utilizing HBsAg-producing transgenic donor cells.
    Gupta S; Chowdhury NR; Jagtiani R; Gustin K; Aragona E; Shafritz DA; Chowdhury JR; Burk RD
    Transplantation; 1990 Sep; 50(3):472-5. PubMed ID: 2402796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte transplantation: an alternative system for evaluating cell survival and immunoisolation.
    Gupta S; Kim SK; Vemuru RP; Aragona E; Yerneni PR; Burk RD; Rha CK
    Int J Artif Organs; 1993 Mar; 16(3):155-63. PubMed ID: 8314640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune tolerance to a defined heterologous antigen after intrasplenic hepatocyte transplantation: implications for gene therapy.
    Vemuru RP; Davidson A; Aragona E; Chowdhury JR; Burk RD; Gupta S
    FASEB J; 1992 Jul; 6(10):2836-42. PubMed ID: 1634046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell type-specific mechanisms regulate hepatitis B virus transgene expression in liver and other organs.
    Aragona E; Burk RD; Ott M; Shafritz DA; Gupta S
    J Pathol; 1996 Dec; 180(4):441-9. PubMed ID: 9014867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice.
    Wirth S; Guidotti LG; Ando K; Schlicht HJ; Chisari FV
    J Immunol; 1995 Mar; 154(5):2504-15. PubMed ID: 7868916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
    Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
    Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice.
    Qu D; Lanier G; Yuan ZH; Wen YM; Howard CR; Ahmed R
    J Med Virol; 2008 Feb; 80(2):225-32. PubMed ID: 18098130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and maintenance of anti-HBs in immunosuppressed murine hepatitis B virus carriers by a novel vaccination approach: implications for use in hepatitis B virus-infected subjects with liver transplantation.
    Furukawa S; Akbar SM; Hasebe A; Horiike N; Onji M
    J Gastroenterol; 2004 Sep; 39(9):851-8. PubMed ID: 15565404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation.
    Gupta S; Aragona E; Vemuru RP; Bhargava KK; Burk RD; Chowdhury JR
    Hepatology; 1991 Jul; 14(1):144-9. PubMed ID: 2066062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents.
    Rajvanshi P; Kerr A; Bhargava KK; Burk RD; Gupta S
    Gastroenterology; 1996 Oct; 111(4):1092-1102. PubMed ID: 8831605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
    Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
    World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Affects of HBV genotypes (B/C) on the levels of serum and intrahepatic HBsAg].
    Chen JJ; Ma SW; Wang ZH; Sun J; Zhu YF; Hou JL
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1947-51. PubMed ID: 17064586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can clamping of splenic vessels prevent abrupt increase of portal vein pressure and migration of transplanted hepatocytes to the liver after intrasplenic hepatocyte transplantation?
    Kim WH; Lee JH; Han SU; Wang HJ; Kim MW
    Hepatogastroenterology; 1998; 45(24):2425-9. PubMed ID: 9951937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of a syngeneic mouse model of liver tumor stably expressing hepatitis B virus antigens].
    Wang Y; Wu ZY; Ren SR; Wei Y; Zhang K; Qu CF
    Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):486-91. PubMed ID: 22967464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
    Manesis EK; Papatheodoridis GV; Tiniakos DG; Hadziyannis ES; Agelopoulou OP; Syminelaki T; Papaioannou C; Nastos T; Karayiannis P
    J Hepatol; 2011 Jul; 55(1):61-8. PubMed ID: 21145875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of liver repopulation using the dipeptidyl peptidase IV-deficient rat and other rodent recipients: cell size and structure relationships regulate capacity for increased transplanted hepatocyte mass in the liver lobule.
    Rajvanshi P; Kerr A; Bhargava KK; Burk RD; Gupta S
    Hepatology; 1996 Mar; 23(3):482-96. PubMed ID: 8617428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y; Guidotti LG; Fowler P; Chisari FV
    J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.
    Malanchère-Brès E; Payette PJ; Mancini M; Tiollais P; Davis HL; Michel ML
    J Virol; 2001 Jul; 75(14):6482-91. PubMed ID: 11413315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.